CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...